Picture your Future. Save for it by earning 1.5% on a 1-year Term Deposit Account! Learn more.

Epic Investment Partners Views: The Week Ahead

Highlights this week include Fed Chair Powell’s semi-annual testimony to Congress (Tues-Wed), the US CPI (Wed) and PPI (Thu), and earnings from the likes of Coca-Cola, and McDonalds. A data free Monday will have markets focused on China’s counter-tariffs on US goods, effective today, and further tariff announcements from the US. On Tuesday we will hear from the Fed’s Hammack, on economic outlook, and Williams. The BoE’s Bailey and Mann speak on financial markets and economic prospects, respectively. US CPI will grab market focus on Wednesday. The Fed’s Bostic, ECB’s Elderson and Nagel, and BoE’s Greene all speak on Wednesday. Germany CPI, UK GDP and US PPI are due on Thursday. Eurozone GDP, and US retail sales, industrial production and business inventories will garner interest on Friday.  

Uncertainty remained a dominant theme last week amid trade war rhetoric. The week began with a pause on US tariffs on Canada and Mexico, for 30 days, following tentative agreements. Meanwhile, the 10% US tariff on Chinese imports resulted in counter-tariffs. The US Treasury 10-year yield fell 4bps to 4.50%, while the S&P Index fell 0.24%. Meanwhile, the US dollar weakened as markets viewed Trump’s tariff threats as negotiation tactics; the DXY Index fell 0.30%. Meanwhile, Brent crude fell 2.74%, as OPEC+ reaffirmed its plans to gradually increase oil production from April.  

Fed chatter was broadly one of caution as officials expressed concerns about trade policy uncertainty. Collins noted tariffs could raise costs for both final and intermediate goods. Goolsbee warned about careful interest rate management, while Bostic highlighted that businesses are preparing for tariff-related cost increases. 

US data releases included the US ISM manufacturing, which surprised to the upside January, breaking back into expansion, at 50.9. The ISM services print disappointed, and interestingly the prices paid component slipped dramatically, although still robust at 60.4. Labour market data was broadly softer-than-expected, ahead of the key employment report on Friday, which was mixed. Non farm payrolls increased by 143 jobs (exp. 175k, prev. 256k), average hourly earnings rose 4.1%yoy and unemployment fell to 4%. The Uni. of Michigan consumer sentiment fell to a seven-month low amid inflation concerns. The Uni. of Michigan inflation expectations surprised with the 1-year revised 100bps higher to 4.3%, while the 5-10 year projections were marginally higher at 3.3%.  

Elsewhere, eurozone CPI unexpectedly increased in January with the headline increasing to 2.5%yoy and core up 2.7%yoy. However, this rise is not expected to alter the ECB’s plans to lower interest rates, though concerns have emerged about potential US tariffs on EU goods and their impact on both growth and inflation. 

The Bank of England cut interest rates by 25bps to 4.50% while halving its UK growth forecast for 2025 from 1.5% to 0.75%. Despite warning that inflation could reach 3.7% by autumn, Governor Andrew Bailey indicated further rate cuts may come this year, citing concerns over weak economic growth and declining business confidence, though he emphasised these would be implemented gradually and carefully. 

Over the weekend we had China’s CPI and PPI for January. CPI to 0.5%yoy marking the fastest growth in five months, driven by lunar new year festivities and seasonal spending on food and services. While this surpassed economists’ predictions and showed an uptick from December’s 0.1%, the broader outlook remains subdued – February could see a contraction exceeding 0.5%, with inflation likely to stay flat in Q1 before a possible modest rise to 1% in Q2. Meanwhile, PPI fell 2.3%yoy, marking its 28th consecutive monthly decline and slightly exceeding economists’ forecasts of a 2.2% drop, indicating that deflationary pressures continue to grip China’s manufacturing sector despite the temporary consumer price boost. 


Epic Investment Partner’s Key risks & Disclaimers:

EPIC Global Equity Fund (the “Fund”) is a sub-fund of EPIC Funds p.l.c. (the “Company”), which is an open-ended umbrella fund authorised in Ireland as a UCITS fund and regulated by the Central Bank of Ireland. This marketing material has been approved in the UK by EPIC Markets (UK) LLP, trading as EPIC Investment Partners, which is a limited liability partnership incorporated and registered in England and Wales under partnership OC306260 with its registered office at Audrey House, 16-20 Ely Place, London EC1N 6SN. EPIC Markets (UK) LLP is regulated by the Financial Conduct Authority. Distribution of this material and the offer of the Fund are specifically restricted in certain jurisdictions. In particular, but without limitation, neither this material nor shares in the Fund are available to US persons.

This document is for general information purposes only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. It is not a personal recommendation and it should not be regarded as a solicitation or an offer to buy or sell any shares in the Fund. This document represents the views of EPIC Investment Partners at the time of writing. It should not be construed as investment advice. Any person interested in investing in the Fund should conduct their own investigation and analysis of the Fund and should consult their own professional tax, accounting or other advisers as to the risks involved in making such an investment. Full details of the Fund’s investment objectives, investment policy and risks are set out in the Fund’s Prospectus and Supplement which, together with the Key Information Document (“KID”), are available on request and free of charge from Maples Fund Services (Ireland) Limited, 32 Molesworth Street, Dublin 2, Ireland and, in the UK, from EPIC Markets (UK) LLP, Audrey House, 16-20 Ely Place, London EC1N 6SN. Any offering of the Fund is only made on the terms of the current Prospectus, Supplement and KID. A subscription in the Fund can only be made after the provision of the KIID and should be made solely upon the information contained in the Prospectus, Supplement and KID.

An investment in the Fund is not suitable for an investor who cannot sustain a loss on their investment. There is no guarantee of the Fund’s future performance and past performance is not a reliable indicator of future performance. The value of your investment and the income derived from it can go down as well as up, and you may not get back the money you invested. The risks associated with making an investment in the Fund are described in the Prospectus and Supplement but investors should note, in particular, the following: 1) Foreign currency denominated investments are subject to fluctuations in exchange rates that could have a positive or an adverse effect on an investor’s returns. There is also a risk that currency hedging transactions for one share class may in extreme cases adversely affect the net asset value of the other share classes within the same sub-fund since there is no legal segregation between share classes; 2) The Fund is subject to the risk of the insolvency of its counterparties; and 3) Emerging market securities are subject to greater social, political, regulatory, and currency risks than developed market securities. This may impact the liquidity and value of such securities and, consequently, the value of the Fund.


MeDirect Disclaimers:

This information has been accurately reproduced, as received from EPIC Investment Partners. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document is intended for retail clients however, it may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Information Document (KID), which may be obtained from MeDirect Bank (Malta) plc.

Join MeDirect today to access the tools you need to put your money to work on your own terms.

Latest news articles

MeDirect employees have joined forces to raise funds for the Inspire Foundation, supporting those in the community with diverse abilities to fulfil their potential.
All News

MeDirect employees support Inspire

MeDirect employees have joined forces to raise funds for the Inspire Foundation, supporting those in the community with diverse abilities to fulfil their potential.

Bright spots in global stocks
All News

BlackRock Commentary: Bright spots in global stocks

Despite a U.S. equity pullback, BlackRock remain overweight U.S. stocks while seeing global opportunities, with Europe’s fiscal boost, Japan’s corporate reforms, and Latin America’s mega forces driving gains, though prolonged U.S. policy uncertainty could pose risks.

Experience better Banking

The sooner you start managing your money, your way, using the best-in-class tools, the sooner you’ll see results. 


Sign up and open your account for free, within minutes.

MeDirect_Multi-Devices-cards

You are leaving medirect.com.mt

Please be aware that the external site policies, or those of another MeDirect website, may differ from this website’s terms and conditions and privacy policy. The next website will open in a new browser window or tab.

 

Note: MeDirect is not responsible for any content on third party sites, nor does a link suggest endorsement of those sites and/or their content.

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.